← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2009Last known activity
Jun 1, 2010
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT01860235Lead sponsorN/AJun 1, 2010
- NCT01860235Reponsible party - principal investigatorN/AJun 1, 2010
- NCT02128633CollaboratorPhase 2/Phase 3Nov 1, 2009
Details
- Last known activity
- Jun 1, 2010